Vastagbélrák: vizsgálatok itt: Hollandia
86 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Where
- Breda, Groningen, Maastricht
- Életkor
- 18 év and over
- People
- 1020 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07549412 · EU 2025-524648-37-00 - 3. fázisTaking peopleA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Where
- Amsterdam, Breda, Nijmegen, Rotterdam
- Életkor
- 18 év and over
- People
- 477 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06997497 · EU 2024-517232-22-00 - 1. fázisTaking peopleA Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Where
- Amsterdam, Maastricht, Nijmegen, Utrecht
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213791 · EU 2025-521887-37-00 - 3. fázisTaking peopleA Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Where
- Amersfoort, Amsterdam, Nijmegen, Rotterdam, Tilburg, Utrecht
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06662786 · EU 2024-513852-13-00 - 3. fázisTaking peopleA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Where
- Amersfoort, Amsterdam, Nijmegen, Rotterdam, Tilburg
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06750094 · EU 2024-513853-66-00 - 1/2. fázisTaking peopleA Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Where
- Amsterdam, Nijmegen, Utrecht
- Életkor
- 18 év and over
- People
- 560 worldwide
- Run by
- Genmab
See details and how to joinNCT03526835 · EU 2024-513627-16-01 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Where
- Amersfoort, Groningen, Maastricht, Rotterdam
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07284849 · EU 2025-523735-19-00 - 2. fázisTaking peopleNeoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Solstice Oncology, Inc.
See details and how to joinNCT07808151 · EU 2026-527233-58-00 - 3. fázisNot yet taking people in HollandiaStudy of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.
- Where
- Arnhem, Rotterdam, Tilburg
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Genmab A/S
See details and how to join2026-525883-17-00 · EU 2026-525883-17-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amsterdam, Groningen, Nijmegen, Rotterdam, Utrecht
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 2/3. fázisTaking peopleA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Where
- Amsterdam, Groningen, Tilburg, Utrecht
- Életkor
- 18 év and over
- People
- 990 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07221357 · EU 2025-523224-45-00 - 2. fázisTaking peoplePan-tumor neoadjuvant basket study of immune check-point inhibition and novel IO combinations (NEOASIS)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 153
- Run by
- Netherlands Cancer Institute
See details and how to joinNCT06279130 · EU 2023-505756-21-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
- Where
- The Hague
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Vividion Therapeutics, Inc.
See details and how to joinNCT07811193 · EU 2026-525507-26-00 - 2. fázisTaking peopleEvaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
- Where
- Leiden
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Delcath Systems Inc.
See details and how to joinNCT06607458 - 1/2. fázisTaking peopleA Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Amsterdam, Maastricht, Rotterdam, Utrecht
- Életkor
- 18 év and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034 - No phaseTaking peopleDETECT: Target Volume for Rectal Endoluminal Radiation Boosting
- Where
- Eindhoven, Maastricht
- Életkor
- 18 év and over
- People
- 50
- Run by
- Maastricht Radiation Oncology
See details and how to joinNCT04927897 - No phaseTaking peopleRegistry Maastro Applicator
- Where
- Maastricht
- Életkor
- 18 év and over
- People
- 999
- Run by
- Maastricht Radiation Oncology
See details and how to joinNCT07501845 - 2. fázisTaking peopleCan we Save the rectum by watchful waiting or transanal surgery following short- or long-course radioTherapy and Additional local oR systemic Treatment for early-stage REctal Cancer?
- Where
- Amsterdam, Arnhem, Breda, Capelle aan den IJssel, Deventer, Eindhoven, Groningen, Hoofddorp, Leeuwarden, Leiden, Maastricht, Nijmegen, Rotterdam, Tilburg, Utrecht, Zwolle
- Életkor
- 18 év and over
- People
- 280
- Run by
- Radboud universitair medisch centrum Stichting
See details and how to join2024-514620-17-00 · EU 2024-514620-17-00 - 3. fázisTaking peopleSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Pfizer
See details and how to joinNCT07222800 · EU 2025-523521-18-00 - 1. fázisTaking peopleA Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Bayer
See details and how to joinNCT07535112 · EU 2025-523648-11-00 - 3. fázisTaking peoplectDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer
- Where
- Almelo, Amersfoort, Amsterdam, Breda, Delft, Dordrecht, Eindhoven, Goes, Groningen, Hoorn Nh, Leeuwarden, Leiden, Nijmegen, Roosendaal, Rotterdam, 'S-Gravenhage, 'S-Hertogenbosch, Sneek, Terneuzen, Tilburg, Uden, Erasmus MC
- Életkor
- 18 év and over
- People
- 103
- Run by
- Erasmus Medical Center
See details and how to joinNCT07188025 · EU 2024-517700-12-00 - 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Amsterdam, Maastricht, Zwolle
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00 - 2. fázisTaking peopleNeoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
- Where
- Amsterdam, Eindhoven, Haarlem, Hilversum, The Hague
- Életkor
- 18 év and over
- People
- 353
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT03026140 · EU 2024-513314-35-00 - No phaseNot yet taking people in HollandiaEndoscopic (EID) Versus Surgical (TAMIS) Local Excision for Early Stage Rectal Cancer
- Where
- Alkmaar, Almere Stad, Amersfoort, Amsterdam, Capelle aan den IJssel, Deventer, Eindhoven, Groningen, Haarlem, Hoorn, Leiden, Nieuwegein, Roermond, Rotterdam, The Hague, Utrecht, Zwolle
- Életkor
- 18 év and over
- People
- 246
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT07846046 - 3. fázisTaking peopleNeoadjuvant FOLFOXIRI and Chemoradiotherapy versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy, followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer
- Where
- Amsterdam, Arnhem, Deventer, Eindhoven, Geldrop, Goes, Heerlen, Helmond, Leeuwarden, Maastricht, Nijmegen, Rotterdam, 'S-Gravenhage, 'S-Hertogenbosch, Utrecht, Veldhoven, Vlissingen, Weert, Zwolle
- Életkor
- 18 év and over
- People
- 394
- Run by
- Catharina Ziekenhuis Stichting
See details and how to joinNCT07472868 · EU 2025-523692-39-00